Recursion Pharmaceuticals... (RXRX)

RXRX trades at $5.49, 22.0% above the near-term max pain of $4.5 expiring Oct 10, 2025 (5 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$6), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 9 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RXRX shows an upward trend from 1 to 6, suggesting bullish positioning in longer-dated options. The 110% spread signals divergent expectations across timeframes. Most levels below 5.49 may cap rallies. Strong magnetic level at 5 (9 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.